SCHEMBL7734952

SCHEMBL7734952

Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(OCC(F)(F)F)c2ccc(F)cc2)[C@@H](O)[C@H]1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.60
▸ WDR77 Q9BQA1 1/20 0.60
▸ AHCY P23526 7/20 0.52
▸ NADK O95544 1/20 0.52
▸ ADORA3 P0DMS8 3/20 0.51
▸ ADORA2A P29274 2/20 0.51
▸ ADORA1 P30542 2/20 0.51
▸ ADORA2B P29275 2/20 0.51
▸ DPP4 P27487 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ SLC28A1 O00337 1/20 0.51
▸ MAP3K7 O43318 1/20 0.51
▸ SLC28A2 O43868 1/20 0.51
▸ GAPDH P04406 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ STAT6 P42226 1/20 0.51
▸ PI4KA P42356 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ PI4K2B Q8TCG2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7732757 0.80 PRMT5 (0.74) PRMT5WDR77AHCYNADKADORA3
SCHEMBL7732588 0.80 PRMT5 (0.59) PRMT5WDR77AHCYNADKADORA3
SCHEMBL7723981 0.79 EHMT1 (0.54) PRMT5WDR77AHCYADORA3ADORA2A
SCHEMBL24626067 0.79 PRMT5 (0.73) PRMT5WDR77AHCY
SCHEMBL800776 0.79 PRMT5 (0.64) PRMT5WDR77AHCYADORA3ADORA2A
SCHEMBL800351 0.79 PRMT5 (0.64) PRMT5WDR77AHCYADORA3ADORA2A
SCHEMBL7157769 0.78 PRMT5 (0.57) PRMT5WDR77AHCYNADKADORA3
SCHEMBL7723990 0.78 ADORA3 (0.51) PRMT5WDR77AHCYNADKADORA3
SCHEMBL674401 0.78 AHCY (0.57) PRMT5WDR77AHCYNADKADORA3
SCHEMBL788626 0.78 AHCY (0.57) PRMT5WDR77AHCYNADKADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407076-B1 ANTIISCHEMIC, ANTILIPOLYTIC, ANTICONVULSANT AND HYPOTENSIVE AGENTS; CARDIOVASCULAR AND NERVOUS SYSTEM DISORDERS; ATHEROSCLEROSIS SMITHKLINE BEECHAM CORPORATION 2002-06-18 — — US claimed
Send feedback